TY - JOUR
T1 - Enterovirus-D68 – a reemerging non-polio enterovirus that causes severe respiratory and neurological disease in children
AU - Grizer, Cassandra S.
AU - Messacar, Kevin
AU - Mattapallil, Joseph J.
N1 - Publisher Copyright:
Copyright © 2024 Grizer, Messacar and Mattapallil.
PY - 2024
Y1 - 2024
N2 - The past decade has seen the global reemergence and rapid spread of enterovirus D68 (EV-D68), a respiratory pathogen that causes severe respiratory illness and paralysis in children. EV-D68 was first isolated in 1962 from children with pneumonia. Sporadic cases and small outbreaks have been reported since then with a major respiratory disease outbreak in 2014 associated with an increased number of children diagnosed with polio-like paralysis. From 2014-2018, major outbreaks were reported every other year in a biennial pattern with > 90% of the cases occurring in children under the age of 16. With the outbreak of SARS-CoV-2 and the subsequent COVID-19 pandemic, there was a significant decrease in the prevalence EV-D68 cases along with other respiratory diseases. However, since the relaxation of pandemic social distancing protocols and masking mandates the number of EV-D68 cases have begun to rise again-culminating in another outbreak in 2022. Here we review the virology, pathogenesis, and the immune response to EV-D68, and discuss the epidemiology of EV-D68 infections and the divergence of contemporary strains from historical strains. Finally, we highlight some of the key challenges in the field that remain to be addressed.
AB - The past decade has seen the global reemergence and rapid spread of enterovirus D68 (EV-D68), a respiratory pathogen that causes severe respiratory illness and paralysis in children. EV-D68 was first isolated in 1962 from children with pneumonia. Sporadic cases and small outbreaks have been reported since then with a major respiratory disease outbreak in 2014 associated with an increased number of children diagnosed with polio-like paralysis. From 2014-2018, major outbreaks were reported every other year in a biennial pattern with > 90% of the cases occurring in children under the age of 16. With the outbreak of SARS-CoV-2 and the subsequent COVID-19 pandemic, there was a significant decrease in the prevalence EV-D68 cases along with other respiratory diseases. However, since the relaxation of pandemic social distancing protocols and masking mandates the number of EV-D68 cases have begun to rise again-culminating in another outbreak in 2022. Here we review the virology, pathogenesis, and the immune response to EV-D68, and discuss the epidemiology of EV-D68 infections and the divergence of contemporary strains from historical strains. Finally, we highlight some of the key challenges in the field that remain to be addressed.
KW - acute flaccid myelitis
KW - children
KW - enterovirus
KW - EV-D68
KW - respiratory distress
UR - http://www.scopus.com/inward/record.url?scp=85195273350&partnerID=8YFLogxK
U2 - 10.3389/fviro.2024.1328457
DO - 10.3389/fviro.2024.1328457
M3 - Review article
AN - SCOPUS:85195273350
SN - 2673-818X
VL - 4
JO - Frontiers in Virology
JF - Frontiers in Virology
M1 - 1328457
ER -